Sekar Kathiresan - Chief Executive Officer, Director at Verve Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
VERV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sekar Kathiresan since 11/23/2023

Holdings reported by Sekar Kathiresan for Verve Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 132K $1.32M $10.00 Feb 14, 2024 Direct Common Stock
Common Stock 351K $1.01M $2.87 Jun 28, 2024 Direct
Common Stock 241K $692K $2.87 Jun 28, 2024 Kathiresan Family 2021 Irrevocable Trust
Common Stock 81K $232K $2.87 Jun 28, 2024 Sekar Kathiresan 2021 Irrevocable Trust
Stock Option (right to buy) 215K Jun 28, 2024 Direct Common Stock
Stock Option (right to buy) 200K Jun 28, 2024 Sekar Kathiresan 2023 Annuity Trust Common Stock 200K
Stock Option (right to buy) 160K Jun 28, 2024 Sekar Kathiresan 2022 Annuity Trust Common Stock 160K

Transactions reported by Sekar Kathiresan for Verve Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.